Skip to content
Leiomyoarcoma.info Logo
  • Home
  • LMS Research Updates
    • Research Projects
    • LMS Research Updates
    • Uterine Leiomyosarcoma Research Updates
    • ASCO Research Presentations
    • Drug Treatment Updates
    • Immunotherapy Updates
    • Gene Editing (CRISPR Cas 9)
    • Radiation Therapy
    • LIQUID BIOPSIES EXPLAINED
    • 2016 Archived Sarcoma/LMS Research News
  • Clinical Trials
    • What is a Clinical Trial?
    • How to Find Clinical Trials
    • DIRECT ACCESS TO CLINICAL TRIAL SITE LINKS- BY SARCOMA CENTERS:
    • TAPUR-Matching Patients with Treatments
  • Videos
    • 2019 ASCO Meeting
    • Miscellaneous Videos
    • Interviews with Researchers
    • LMS specific presentations from CTOS 2018
  • Patient Data Collection Programs
    • Broad Institute Cancer Cell Line Project
    • CANCERLINQ Information Video for patients:
    • MyPart Network / Count Me In Project
    • ORIEN-Oncology Research Information Exchange Network
  • International Research Roundtable Forum
  • Uterine LMS Research Updates
  • About Us
  • Menu

Drug Treatment Updates

Pill, Capsule, Medicine, Medical, Health

For additional updates, please cross reference clinical trials section.

Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes

Aldoxorubicin shows promise in advanced soft tissue sarcoma  video by Dr. Sant Chawla, 2017

Aldoxorubicin for the treatment of soft tissue sarcoma

Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas

CytRx to Present Aldoxorubicin Clinical Trial Data in Patients with Soft Tissue Sarcomas at the 2017 American Society of Clinical Oncology Annual Meeting (ASCO) 

Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of phase 3, randomized clinical trial.

Identification of microRNA biomarkers for the response of advanced soft tissue sarcomas to eribulin: Translational results of the EORTC 62052 trial

Mechanism of action and tolerability of trabectedin for liposarcoma and leiomyosarcoma

Olaratumumab and leiomyosarcoma  video by Dr. Brian Van Tine, 2016

Pazopanib Regimen Active, But Misses Mark in Leiomyosarcoma

Pembrolizumab Active in Few Soft Tissue, Bone Sarcoma Subtypes

Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin

A SiteOrigin Theme